ELIZABETH MIRANDA: Open Payments
NPI 1356870257 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 15 payments from 10 companies in 2025. Trend: 2023 $121 · 2024 $352 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| ABBVIE INC. | 2 | $35 |
| Lilly USA, LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| SK Life Science, Inc. | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
| UCB, Inc. | 1 | $16 |
Products named: PONVORY, XIFAXAN, KISUNLA, INGREZZA, ULTOMIRIS, Leqembi, BOTOX, VYALEV.
Industry payments across NJ — which companies pay providers there.
